Top Story

AMA, Omada Health, Intermountain Healthcare form initiative to prevent type 2 diabetes

July 30, 2016

The American Medical Association, digital health company Omada Health, and nonprofit health care system Intermountain Healthcare, based in Utah, announced a collaborative initiative to provide an online lifestyle-change program aimed at reducing the number of people who develop type 2 diabetes, according to a press release.

This initiative will bring together Omada’s online technology and AMA’s comprehensive efforts to prevent type 2 diabetes to provide Intermountain’s physicians and patients with online, personalized evidence-based prevention programs to aid in preventing type 2 diabetes.

In the Journals Plus

Adherence to diabetes prevention program reduces risk for disease progression

July 29, 2016
Patients with prediabetes who adhered to a relatively low-cost, practical diabetes prevention program progressed to diabetes at a lower rate than those who attended only…
In the Journals Plus

Thyroid cancer risk increases with hysterectomy

July 29, 2016
Among postmenopausal women, the risk for thyroid cancer is increased with hysterectomy regardless of oophorectomy status, according to recently published data. Use of…
Meeting News CoverageVideo

VIDEO: EMPA-REG, LEADER trial results produce ‘exciting time’ for diabetes care

July 29, 2016
NEW ORLEANS — The results of the EMPA-REG Outcome study and the LEADER trial have expanded physicians’ armamentariums to be able to decrease patients with…
FDA News

FDA fast-track designation granted for type 1 diabetes treatment

July 29, 2016
The FDA granted a Fast Track designation to Caladrius Biosciences Inc. for its product candidate CLBS03 for the treatment of type 1 diabetes, according to a press…
More News Headlines »
CME Video

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Meeting News Coverage

VIDEO: Results of faster-acting insulin trials reported

June 17, 2016
More »
Highlights from AACE

Highlights from AACE


Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Current Issues
View the Current Issues